Swiss-based confectioner Nestle is reportedly reducing its grip on France beauty product maker L’Oreal, reports say, as L’Oreal plans to buy back some of its shares.
To finance the re-acquisition of the stock, L’Oreal will reportedly divest its 50 percent stake in Swiss dermatology pharmaceutical Galderma; the company is a joint venture between Nestle and L’Oreal. Nestle will pay L’Oreal about $4.2 billion for the sale.
An additional $4.6 billion of the deal will be paid in cash by L’Oreal.
The shake-up in L’Oreal and Nestle’s partnership will also result in a reduction of Nestle representatives on the L’Oreal board, from three to two directors.
Competition authorities will need to clear the planned transactions.
Full Content: FoodBev
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Nvidia and Microsoft Sued for Allegedly Undercutting AI Technology Patent Prices
Sep 5, 2024 by
CPI
White & Case Strengthens Antitrust and M&A Practices with New Partner Additions
Sep 5, 2024 by
CPI
Federal Judge Dismisses Antitrust Lawyers’ Fee Demand Over JetBlue-Spirit Deal
Sep 5, 2024 by
CPI
Boston Landlords Named as US Sues RealPage Over Alleged Rent-Inflating Practices
Sep 5, 2024 by
CPI
Judge to Weigh Landmark NCAA Settlement Proposal in Antitrust Lawsuit
Sep 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI